• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔镜袖状胃切除术患者脂肪肝疾病分级与围手术期危险因素的比较

Comparison of the Grades of Fatty Liver Disease With Perioperative Risk Factors in Patients With Laparoscopic Sleeve Gastrectomy.

作者信息

Kara Yalçın Burak, Ozel Yahya

机构信息

Department of General Surgery, Bahcesehir University, School of Medicine, Istanbul, TUR.

Department of General Surgery, Medical Park Pendik Hospital, Istanbul, TUR.

出版信息

Cureus. 2024 Sep 19;16(9):e69717. doi: 10.7759/cureus.69717. eCollection 2024 Sep.

DOI:10.7759/cureus.69717
PMID:39429298
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11490200/
Abstract

Background Obesity is a global healthcare problem, and nonalcoholic fatty liver disease (NAFLD) is a commonly observed comorbid disease in the bariatric population. This study evaluated the relationship between NAFLD and various risk factors, including demographic, biochemical, and comorbid conditions in patients undergoing laparoscopic sleeve gastrectomy (LSG). Material and methods This retrospective data analysis study included patients who underwent LSG between August 2023 and 2024. Patient demographic data were collected, such as age, gender, weight, and body mass index (BMI), and NAFLD grade was determined by ultrasonography. Biochemical markers were recorded, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), total cholesterol, triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), fasting blood glucose (FBG), HbA1c, and vitamin D. The presence of type II diabetes mellitus (T2DM) and hypertension (HT) was evaluated and compared with the grade of hepatosteatosis. Results The study included 436 patients, of whom 73.6% ( = 321) were female. The mean age was 37.23 ± 10.49 years, and the mean BMI value was 41.25 ± 6.11 kg/m. Patients were classified and compared according to their NAFLD grade, revealing statistically significant differences in weight, BMI, ALT, AST, HDL, LDL, TG, total cholesterol, HbA1c, FBG, vitamin D, obesity class, DM, and HT ( 005). HDL and vitamin D showed an inverse correlation with NAFLD. We observed no significant difference in the relationship of NAFLD with age and the presence of gallstone. Logistic regression analysis revealed that ALT, AST, LDL, total cholesterol, and FBG were statistically significantly associated with NAFLD in the multivariate model. Conclusion Hepatosteatosis, T2DM, and HT are frequent comorbid diseases that are common in bariatric patients. Our study shows that ALT, AST, LDL, FBG, and total cholesterol may be used as predictors of NAFLD.

摘要

背景

肥胖是一个全球性的医疗保健问题,非酒精性脂肪性肝病(NAFLD)是肥胖人群中常见的合并症。本研究评估了接受腹腔镜袖状胃切除术(LSG)患者的NAFLD与各种风险因素之间的关系,这些因素包括人口统计学、生化指标和合并症。

材料与方法

这项回顾性数据分析研究纳入了2023年8月至2024年期间接受LSG的患者。收集患者的人口统计学数据,如年龄、性别、体重和体重指数(BMI),并通过超声检查确定NAFLD分级。记录生化指标,包括丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、总胆固醇、甘油三酯(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、空腹血糖(FBG)、糖化血红蛋白(HbA1c)和维生素D。评估II型糖尿病(T2DM)和高血压(HT)的存在情况,并与肝脂肪变性分级进行比较。

结果

该研究纳入了436例患者,其中73.6%(n = 321)为女性。平均年龄为37.23±10.49岁,平均BMI值为41.25±6.11kg/m²。根据NAFLD分级对患者进行分类和比较,结果显示体重、BMI、ALT、AST、HDL、LDL、TG、总胆固醇、HbA1c、FBG、维生素D、肥胖类别、糖尿病和高血压存在统计学显著差异(P < 0.05)。HDL和维生素D与NAFLD呈负相关。我们观察到NAFLD与年龄及胆结石存在情况之间的关系无显著差异。逻辑回归分析显示,在多变量模型中,ALT、AST、LDL、总胆固醇和FBG与NAFLD在统计学上显著相关。

结论

肝脂肪变性、T2DM和HT是肥胖症患者常见的合并症。我们的研究表明,ALT、AST、LDL、FBG和总胆固醇可作为NAFLD的预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8ca/11490200/13a9128e5370/cureus-0016-00000069717-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8ca/11490200/13a9128e5370/cureus-0016-00000069717-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8ca/11490200/13a9128e5370/cureus-0016-00000069717-i01.jpg

相似文献

1
Comparison of the Grades of Fatty Liver Disease With Perioperative Risk Factors in Patients With Laparoscopic Sleeve Gastrectomy.腹腔镜袖状胃切除术患者脂肪肝疾病分级与围手术期危险因素的比较
Cureus. 2024 Sep 19;16(9):e69717. doi: 10.7759/cureus.69717. eCollection 2024 Sep.
2
The Effect of Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgery on Non-Alcoholic Steatohepatitis in Iranian Patients with Obesity.腹腔镜袖状胃切除术和胃旁路手术对伊朗肥胖患者非酒精性脂肪性肝炎的影响。
Middle East J Dig Dis. 2021 Jul;13(3):200-207. doi: 10.34172/mejdd.2021.226. Epub 2021 May 11.
3
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.肥胖和代谢综合征作为通过超声诊断的非酒精性脂肪性肝病发生的风险因素。
Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P.
4
Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.年龄在 45-60 岁的中国人群中,非酒精性脂肪肝与高血压之间的相关性存在性别差异。
Clin Exp Hypertens. 2016;38(7):639-643. doi: 10.1080/10641963.2016.1182181. Epub 2016 Sep 28.
5
Analysis of risk factors related to nonalcoholic fatty liver disease: a retrospective study based on 31,718 adult Chinese individuals.非酒精性脂肪性肝病相关危险因素分析:一项基于31718名中国成年个体的回顾性研究。
Front Med (Lausanne). 2023 Jun 29;10:1168499. doi: 10.3389/fmed.2023.1168499. eCollection 2023.
6
Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.中国人 2 型糖尿病患者抵抗素+299A/A 基因型与非酒精性脂肪性肝病的关系。
Gene. 2013 Oct 25;529(2):340-4. doi: 10.1016/j.gene.2013.08.001. Epub 2013 Aug 14.
7
Clinical model to predict the risk of nonalcoholic fatty liver disease: A secondary analysis of data from a cross-sectional study.临床模型预测非酒精性脂肪性肝病风险:一项横断面研究数据的二次分析。
Medicine (Baltimore). 2024 Sep 6;103(36):e39437. doi: 10.1097/MD.0000000000039437.
8
IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.2 型糖尿病对非酒精性脂肪性肝病患者非酒精性脂肪性肝炎和肝纤维化进展的影响。
Endocr Pract. 2020 Apr;26(4):444-453. doi: 10.4158/EP-2019-0342. Epub 2020 Jan 22.
9
Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial.维生素 D 与儿童非酒精性脂肪肝:一项随机对照临床试验。
Eur J Pediatr. 2022 Feb;181(2):579-586. doi: 10.1007/s00431-021-04243-4. Epub 2021 Aug 30.
10
Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.前瞻性研究随访 1 年:BariScan 研究显示减重手术可有效治疗非酒精性脂肪性肝病。
Obes Surg. 2018 May;28(5):1342-1350. doi: 10.1007/s11695-017-3012-z.

本文引用的文献

1
Efficacy of Omentopexy on Complications of Laparoscopic Sleeve Gastrectomy.网膜固定术对腹腔镜袖状胃切除术并发症的疗效。
Obes Surg. 2024 Sep;34(9):3298-3305. doi: 10.1007/s11695-024-07363-6. Epub 2024 Jun 24.
2
American Society for Metabolic and Bariatric Surgery 2022 estimate of metabolic and bariatric procedures performed in the United States.美国代谢与减重外科学会 2022 年美国代谢与减重手术实施预估。
Surg Obes Relat Dis. 2024 May;20(5):425-431. doi: 10.1016/j.soard.2024.01.012. Epub 2024 Feb 1.
3
A Simple Way to Estimate a Difficult Sleeve Gastrectomy Prior to Operating.
一种在手术前估算困难胃袖状切除术的简单方法。
Obes Surg. 2024 Apr;34(4):1159-1167. doi: 10.1007/s11695-024-07093-9. Epub 2024 Feb 19.
4
IFSO Consensus on Definitions and Clinical Practice Guidelines for Obesity Management-an International Delphi Study.国际肥胖管理共识定义和临床实践指南——一项国际 Delphi 研究。
Obes Surg. 2024 Jan;34(1):30-42. doi: 10.1007/s11695-023-06913-8. Epub 2023 Nov 24.
5
Non-alcoholic fatty liver disease: relation to juvenile obesity, lipid profile, and hepatic enzymes.非酒精性脂肪性肝病:与青少年肥胖、血脂谱和肝酶的关系。
J Med Life. 2023 Jan;16(1):42-47. doi: 10.25122/jml-2022-0091.
6
Enhanced Recovery After Surgery Promotes Recovery in Sleeve Gastrectomy: A Randomized Controlled Trial.手术后加速康复促进袖状胃切除术的恢复:一项随机对照试验。
J Laparoendosc Adv Surg Tech A. 2023 May;33(5):452-458. doi: 10.1089/lap.2022.0494. Epub 2022 Dec 26.
7
Global incidence and prevalence of nonalcoholic fatty liver disease.全球非酒精性脂肪性肝病的发病率和患病率。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S32-S42. doi: 10.3350/cmh.2022.0365. Epub 2022 Dec 14.
8
2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery.2022 年美国代谢与减重外科学会(ASMBS)和国际肥胖与代谢外科联合会(IFSO)代谢与减重手术适应证。
Obes Surg. 2023 Jan;33(1):3-14. doi: 10.1007/s11695-022-06332-1.
9
A Multidisciplinary Approach and Current Perspective of Nonalcoholic Fatty Liver Disease: A Systematic Review.非酒精性脂肪性肝病的多学科方法与当前观点:一项系统综述
Cureus. 2022 Sep 27;14(9):e29657. doi: 10.7759/cureus.29657. eCollection 2022 Sep.
10
Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss.非酒精性脂肪性肝病(NAFLD):病理生理学、临床管理和减肥效果的综述。
BMC Endocr Disord. 2022 Mar 14;22(1):63. doi: 10.1186/s12902-022-00980-1.